ILCA 2023 | Dynamic Changes in Circulating Tumor DNA Assist in Guiding and Evaluating Clinical Treatment of Liver Cancer
Circulating tumor DNA (ctDNA) refers to free tumor DNA fragments located in peripheral circulation. These free nucleic acids not only provide a comprehensive view of tumor genetics but also indirectly reflect tumor progression, heterogeneity, and invasive ability. They represent a promising non-invasive biomarker in cancer treatment. Dr. Claudia Campani from the University of Paris delivered an oral presentation at the 17th International Liver Cancer Association Annual Meeting (ILCA 2023) (Abstract No.: O-04). The study aimed to assess the dynamic changes in ctDNA levels in hepatocellular carcinoma (HCC) patients across different tumor stages and during anti-cancer treatments. The findings highlighted the significant clinical relevance of monitoring ctDNA levels for HCC patients. Dr. Claudia Campani was honored with the "Young Investigator" award by the ILCA conference.